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Abstract

THE ROLE OF SULFATIDE IN ALZHEIMER'S DISEASE
By Charles Britton Beasley, Jr., B.S. Biology
A Thesis submitted in partial fulfillment of the requirements for the degree of Master's in
Anatomy and Neurobiology at Virginia Conmonwealth University.
Virginia Commonwealth University, 2006
Major Director: Jeffrey Dupree, Ph.D.
Assistant Professor, Department of Anatomy and Neurobiology

Alzheimer's disease (AD) is characterized by the accumulation of amyloid beta
plaques, neurofibrillary tangles (NFT) and loss of cortical neurons that control memory
and cognition. The cause of NFTs and AP plaques is not clear, though it is known that they
are formed by enzymes which are preferentially sequestered to membrane domains called
lipid rafts. Sulfatide (ST) is a glycosphingolipid that is essential for the proper structure
and function of lipid rafts. In mice that lack ST, membrane domains that are normally
maintained by adhesive contacts and functional lipid rafts are improperly formed and are
unstable. In these ST null mice, voltage gated sodium channels, neuronal proteins that
vii

...
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normally cluster at the nodes of Ranvier, initially accumulate in the node but are not
retained with age. Taken together the findings from the ST null mice indicate that
membrane organization is compromised. Recently, a published report demonstrated that
ST is significantly reduced in AD. Based on this observation combined with the findings
Erom the ST null mice, I propose that membrane architecture is also altered in AD and this
alteration may facilitate AD pathogenesis. To test this hypothesis, I have used an
imrnunohistochemical approach to assess neuronal membrane organization in AD and non-

AD brain samples. Analysis of the sodium channel clusters was chosen since these nodal
domains provide an easy assessment tool for membrane organization. In the current study,
sodium channel domains were not altered and no change in isoform expression was
observed. Based on these fmdings, membrane organization does not appear to be altered in

AD. It is important to note, however, that sodium channel clusters are restricted to a
specific region of the axon and thus membrane organization within other regions of the
axon and in other regions of the neuron may be altered. Additionally, assessment of the
brain samples, using thin layer chromatography, did not show a reduction in ST levels
between the AD and non-AD brains. Therefore, my study strongly suggests that M e r
analysis of ST levels in AD brains sould be conducted to resolve the contrasting results
between the current study and the previously published work.

Introduction

Overview of Alzheimer's Disease

Alzheimer's disease (AD) is the most prevalent cause of neural degeneration and
dementia in the rapidly growing elderly population. Patients with AD experience mild to
severe dementia including progressive memory loss. Though the trends resemble those of
the normal aging brain, symptoms are significantly exaggerated in AD. Age is the most
important risk factor. The characteristic pathologies at the microscopic level are arnyloid
beta (AP) plaques and neurofibrillary tangles (NFT). Though these are well-established
indicators, much remains to be understood about their formation. (reviewed by Armstrong,
2006).
Diagnosis of AD involves both psychological analysis for the presence and level of
dementia and post-mortem morphological testing for AP plaques and NFTs. The rninimental state examination (MMSE) and the AD assessment scale (ADAS) are both used as
objective measures of progression of cognitive impairment (Schmitt et al., 2002). In
addition to the MMSE and ADAS classifications, Braak and Braak (1991) developed a
staging system for the disease that is based on the degree and location of NFTs. Braak and
Braak demonstrated that levels of AD correlated with the patterns and extent of NFT
formation. In this system, stages I and I1 are characterized by mild to severe alteration of
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the transentorhinal layer; stages I11 and IV involve the proper entorhinal cortex, and stages

V and VI show destruction of isocortical association areas as well. Magnetic resonance
imaging for loss of gray and white matter is also used in the diagnosis (Karas et al., 2004;
Sjobeck et al., 2006).

AD can be divided into familial and non-familial categories. Familial AD is
usually associated with early onset and often involves mutations in the APP gene or
presenilins. Gottries et al., (1996) used confusional symptomatology and parietal
pathology to differentiate between the two categories. Parietal pathology was associated
more with the early AD and confusioanl symptomatology with late onset.
The cause of Alzheimer's remains unknown. Various treatments including
acetylchoinesterase (AChE) inhibitors and new experimental therapies using AP antibodies
have been used with minimal success. AChE has been very effective in providing
incremental increase in cognitive ability by increasing levels of acetylcholine, but has no
effect on the underlying pathology. The use of antibodies is still under examination.

Histopathology of Alzheimer's Disease

The underlying cause of dementia in AD is loss of neurons. Specifically, this loss
is seen in pyramidal and interneurons in the entorhinal neocortices, the nucleus basalis,
basal forebrain, and pyramidal neurons in the CAI and CA2 regions of the hippocampus.
This loss of cells leads to gross brain changes such as reduction in overall brain size,
widened sulci, narrowed gyri, and dilated ventricles. Microscopic analysis using silver

stains reveals the two hallmark pathologies that are NFTs and AP plaques (Figure 1).
NFTs are found intracellularly and AP plaques extracellularly (DeArmond, 1997).
NFTs are not unique to AD, although they are a necessary histological finding for

AD diagnosis (Braak and Braak, 1991). They are also found in Parkinson's and
amyotrophic lateral sclerosis (Kokubo and Kuzuhara, 2004). Tangles are formed in
neuronal cell bodies as a result of hyperphosphorylation of the microtubule associated
protein tau. Hyperphosphorylationof tau results in the formation of paired helical
filaments (PHF), which are the building blocks of NFTs. Microtubule associated protein
kinase, glycogen synthase kinase-3, cyclin-dependant kinase 2, cyclin-dependant kinase 5,
calcium/calmodulin-dependent protein kinase 11, protein kinase A, and fyn kinase have

been shown to be involved in this hyperactive phosphorylation (Drewes et al., 1992;
Madelkow et al., 1992; Baumann et al., 1993). Fyn and cdk are associated with lipid rafts
as well (Kramer et al., 1999). Reduced phosphatase activity has also been reported in AD
and implicated in the formation of tangles (Matsuo et al., 1994; Iqbal et al., 1994). Though
tau is normally phosphorylated only at sites outside the microtubule (MT) binding region,
in PHFs phosphorylation is found at sites within .the MT binding region (De Armond,
1997).When abnormally phosphorylated, tau does not bind properly to MTs, but rather
associates with itself (De Armond, 1997).

Figure 1: Hallmark histopathologies in Alzheimer's disease: neurofibrillary tangles and
arnyloid beta plaques. (Taken from American Health Assistance Foundation:
http://www.ahaf.org/alzdis/about/AmyloidPlaques.htm)

Figure 1: Illustration of neurofibrillary tangles and amyloid beta plaques

The theoretical course then, by which NFTs prove toxic to neurons consists of the
following steps as described by Trojanowski and Lee, (2005): First, the abnormal
hyperphosphorylation of tau leads to tau aggreagation. This leads to a decrease in MTbound tau and then to MT depolymerization. Axonal transport is impaired as a result, and
leads to stasis and aggregation of axonal traffic. Function at the synapse is compromised
and axons degenerate and disconnect.
As mentioned above, AP plaques are the other of the classic neuropathologic
hallmarks of AD and are also required for AD diagnosis. These plaques are the product of
an alternate cleavage of the type I transmembrane protein, amyloid precursor protein
(APP) (Figure 2). APP is ubiquitously expressed protein whose function remains unclear.
There are two types of APP cleavage, alpha-gamma and beta-gamma, both of which occur
on the ltunenal side of membranes (Greenfield et al., 1999). The alpha-gamma cleavage
(non-amyloidogenic) consists of a cut at the alpha site by alpha-secretases, which occurs at
the cell membrane. Several zinc metaloproteinases and the aspartyl proteinase betaamyloid cleavage enzyme 2, that are present mostly at the cell surface, are responsible for
the cut at the alpha site. This cleavage is followed by another cut at the gamma site within
the transmembrane domain of APP by the multimaic protein complex known as the
gamma secretase. The gamma cleavage occurs mainly in endocytotic vesicles The alphagamma sequence is the normal non-pathologic event that occurs 95% of the time.
In AD, the beta-gamma (amyloidogenic) sequence becomes more prevalent,
resulting in the deposit of the toxic AP peptides (Vetrivel and Thinakaran, 2006). In this
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pathologic state, the alpha cleavage is replaced by a beta-cleavage occuring mainly on the
membrane of endocytotic vesicles by the membrane bound beta-amyloid cleavage enzyme
1 (BACE 1 or just BACE). AP peptides are exocytosed and accumulate to form plaques or
soluble oligomers in the extracellular space. This accumulation primarily occurs in the
cerebral cortex in associational areas (Hof and Mobbs, 2001) and is considered to be one of
the early events of AD. Although the direct consequence of these AP aggregates is
unknown, they may contribute to inflammation (reviewed by Minghettis, 2005) and altered
ion transport (as reviewed by Kourie, 2001), both of which are possible players in AD.
AP peptides are found in several isoforms including 1-40, 1-42, and 1-43 called
protofibrils (Figure 2). The 42 residue protofibril has the highest tendency to aggregate
and accumulate in the extracellular space. Although the 1-40 isoform does aggreagate,
these oligomers are very unstable. The amyloid cascade hypothesis, which has been one of
the most prominent theories of AD pathogenesis, holds that the fibrillar plaques formed by
AP 1-42 are responsible for neuronal death (reviewed by Klein, 2002). Evidence has
shown that the location of insoluble Af3 shows poor correlation to the region of cell death,
and quantity of these plaques show poor association with degree of dementia (reviewed by
Klein, 2002). Soluble oligomers of AP 1-42 however have a significant correlation with
synapse loss. Levels of 1-42 are correlated with memory loss and regionally associated
with neuron death, making soluble AP seem the more likely culprit in AP.

Figure 2: a) Location and amino acid sequence of amyloid precursor protein. P and a
cleavage sites shown on the lurninal side of the membrane. y cleavage sites (40 and 42)
shown in the intramembrane domain. b) Non-amyloidogenic sequence of cleavage events
( a followed by y). c) Arnyloidogenic (pathologic) cleavage sequence (P followed by y).
(taken from Vetrivel and Thinakaran, 2006)
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The means by which NFTs and AP form are unknown for non-familial AD. One
possibility for the pathogensis is that the enzymes that generate these pathologies become
abnormally localized in membrane domains called lipid rafts.

Lipid Rafts and Sphingolipids

The traditional model of cell membrane architecture describes a homogenous freefloating lateral organization of the cell membrane, though it has become clear that domains
of tight lipid packing occur especially in the outer leaflet. These domains are highly
enriched in cholesterol and sphingolipids that are able to pack tightly due to weak
interactions of the carbohydrate head groups of the glycosphingolipids (as reviewed by
Simons and Ikonen, 1997) and saturation of their hydrocarbon chains. These rafts are able
to move freely within the membrane and can cluster upon interaction of the proteins that
are associated with them (as reviewed by Rajendran and Simons, 2005). Various proteins
preferentially partition into the rafts such as glycosylphosphatidyl-inositol (GP1)-anchored
proteins, tyrosine kinases, G-proteins and other transmembrane proteins (Rajendron and
Simons, 2004). These proteins are likely recruited to these membrane microdomains for
the purpose of signaling and adhesion. Some of these proteins include enzymes whose
activity is influenced by the integrity and clustering of these rafts (as reviewed by Simons
and Ikonen, 1997).
Interestingly, it has been recently shown that one of these glycosphingolipids,
Sulfatide (ST) has levels that are uniquely reduced in AD. Han et al. (2002) showed that
ST is decreased in AD tissue using mass spectrometry, and Gottfries et al. (1996) obtained
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the same results using thin layer chromatography. This loss of ST and ensuing disturbance
of lipid rafts may lead to abnormal distribution of enzymatic activity in the brain, resulting
in the formation of the hallmark histopathologies of AD.
It has been suggested that rafts may be involved in the formation of Afl plaques and
NFTs of AD via the improper recruitment of enzymes or loss of compartmentalization (as
reviewed by Cordy et al., 2006). The secretases and kinases that form the plaques and
tangles, respectively, are known to be preferentially partitioned into these membrane
domains (Kramer et al., 1999). Abnormal proportions of raft lipids have been shown to
alter the &I.rities of these enzymes for rafts and therefore enzymatic activity (Kalvodova
et al., 2005; Kramer et al., 1999).
One example of enzyme activity conveyed by aggregation of raft proteins is that of
fyn kinase as evidenced by Kramer et al. (1999). This example is especially relevant to the
study at hand since fyn is involved in the hyper-phosphorylation of tau which results in
NFTs (Lee et al., 2004). Glycoshpingolipids such as sulfatide, which are enriched in rafts,
are synthesized at the same stage in the maturing OL as fyn coupled GPI-linked proteins
get associated into rafts. In these early myelinating cells fyn kinase is highly active and
linked to rafts. In OL progenitors or other membranes without rafts, fyn does not show the
same activity. Also, addition of an antibody that leads to crosslinking of this fyn-coupled
protein increases fyn activity. These results suggest that rafts are in fact a necessary
platform for fyn enzyme activity that is directly implicated in formation of one of the
hallmark AD microscopic pathologies (Kramer, 1999).

12
Cyclin dependant kinase 5 (cdk5) is also very pertinent to a raft-related theory of

AD pathogenesis. Cdk5 is another of the numerous kinases responsible for the
hyperphosphorylation of tau (Baunlan et al., 1993). Furthermore, cdk5 activity is
regulated by p35, and activator that associates with the cell membrane (Monaco et al.,
2004), potentially with lipid rafts through N-terminal myristalation (Giese et al., 2005).
Griffith et al. (2004) recently showed that only plasma membrane associated cdk5, which
was complexed with p35, displayed activity. Improper membrane recruitment of this
activator results in the mislocalized and prolonged activity of cdk5 potentially inducing tau
hyperphosphorylation (Patrick et al., 1999)
APP is also associated with lipid rafts. It has also been shown that BACE, the
enzyme responsible for the P-cleaveage of APP (Hussain et al., 1999), is selectively
partitioned into rafts (Ehehalt et al., 2003). This occurs since BACE undergoes
palmitoylation, which targets proteins to rafts (as reviewed by Vetrivel and Thinakaran,
2006). Addition of a GPI-anchor, which localizes proteins to rafts, to BACE increased the
cleavage of APP at the f3 site (Cordy et al., 2003; Ehehalt et al., 2003). All four
components of the gamma-secretase complex are also localized to these detergent
insoluble membrane regions (Vetrivel et al., 2004). Also, Chen et al. (2006) showed that
the intracellular domain of APP is associated with the raft protein flotillin-1. Using in vitro
experiments in which concentrations of lipids found in rafts were varied, Kalvadova et al.
(2005) showed that the ratio of lipids directly affects the activity of BACE. In addition,
the alpha secretases responsible for normal processing of APP have not been linked to
these lipid microdomains (Ehehalt et al., 2003).

A critical problem is how to test our hypothesis that altered raft formation due to
reduced ST leads to AD pathogenesis. To possibly solve this dilemma, we will draw on
results from our laboratory studying a knockout mouse in which the synthetic enzyme for
Sulfatide, cerebroside sulfotransferase (CST), has been eliminated. ST is greatly enriched
in oligodendrocytes (Norton et al., 1975), the myelin-forming cells in the CNS.
Interestingly, the knockout animals consistently show dramatic changes in the myelin
sheath, and specifically in the axonal-oligodendroglial junctions in the paranodal region,
which is normally maintained by adhesion molecules sequestered into lipid rafts.
Importantly, these mutant animals show altered distributions of ion channels which are
normally uniquely sequestered in the axon plasma membrane. Since this re-distribution
has been seen in the mutant animals due to loss of ST and potentially abnormal lipid rafts,
we will examine AD brains for a similar redistribution which may be reflective of more
global membrane changes specifically related to the pathogenesis of AD. Furthermore, the
ST knockout mouse shows gray matter (GM) changes including neuronal death (Marcus et
al., 2006), a finding consistent with AD pathology. The following sections briefly discuss
the role of ST in nervous tissue, the importance of normal axon-oligodendroglialjunctions
and summarizes our results from experiements utilizing the CST mutant animals.

The role of ST in axon-oligodendroglial interactions

ST is a glycosphingolipid predominately synthesized by OLs in the CNS and
therefore primarily found in myelin (Vos et al., 1994; Han et al., 2002). ST is found in
hydroxylated and non-hydroxylated forms. The hydroxyl group is on the alpha carbon of
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the fatty acid chain. Carbon chain lengths of ST vary from 16 to 26. ST is present in
white matter (WM) and GM although it is much more prevalent in WM (Han et al., 2002;
Krafft et al., 2005). ST accumulation due to enzymatic dysfunctions is involved in the
pathogenesis of various human diseases such as metachromatic leukodystrophy and
Krabbe's Disease (Han et al., 2002). Cerebroside sulfotransferase (CST) synthesizes ST
by the sulfation of galactocerebroside (GalC) (Honke et al., 1997) Figure 3). ST mediates
various biological processes such as cell regulation, protein tracking,

signal transduction,

cell adhesion, neuronal plasticity, and morphogenesis (reviews by Vos et al., 1994;
Ishizuka, 1997; and Merrill et al., 1997).
ST may regulate neuronal viability by involvement in interactions between axons
and OLs. Also, OLs are required fir development, function and survival of neurons. The
interaction of the axon and OL at the paranode is likely the means through which OLs are
involved in these functions. One way ST may mediate axo-glial interactions is via the
maintenance of OL membrane domains.

Axon-oligodendroglial junctions

The junction of the myelin sheath and the axon is characterized primarily by the
interactions of several membrane proteins at the paranode that serve in adhesion (Menegoz
et al., 1997), signaling (reviewed by Arroyo and Scherer, 2000), and membrane
compartmentalization(Einheber et al., 1997). (Figure 4) The adhesion molecule
CASPR/Paranodin/NCPl (CASPR) is present on the axonal side and associates with
neurofascin (Nfasc) 155 in the OL membrane for the purpose of adhesion (Tait et al.,

2000). The binding of CASPR to Nfasc 155 is essential for the formation of a structural
component of the myelin-axon junction known as transverse bands. These "bands"
provide the junction with a physical appearance that resembles invertebrate septate
junctions which prevent fiee lateral difhsion of molecules along the membrane. When
these junctions are compromised, both glial and neuronal protein domains are disrupted
(Dupree et al., 1999; Bhat et al., 2001).
The proper hctioning of the junction is crucial to maintaining axolemmal protein
clustering. Although other factors may be involved (Kaplan et al., 1997), both initial
clustering (Dugandzija-Novakovic et a1.1995) and long-term domain maintenance (Dupree
et al., 2005) both require physical contact between the glial cell and the neuron. Sodium
and potassium channel clusters are maintained by these junctions and are easily studied via
immunohistochemistry (IHC). Additionally, clustering of these channels is a valuable
indicator of junctional integrity (Dupree et al., 1999).
Sodium channels are multi-domain membrane spanning proteins (Aidley, 1998)
that provide the means by which sodium ions rapidly pass through the axolemma as action
potentials travel down the axon. In the CNS two types of sodium channels (Navl.2 and
Navl.6) have been found clustered at the node (Boiko et al., 2001; Kaplan et al., 2001).
Navl.2 is the immature form and is initially expressed in the CNS nodes of Ranvier. As
myelination continues, Navl.2 is replaced in over 90% of the CNS nodes by the mature
form Navl.6. Following a demyelinating event (Dupree et al., 2005) and in
dysmyelinating animal models (Craner et al., 2003; 2004; Suzuki et al., 2004), Navl.2

Figure 3: Sulfatide is synthesized from the addition of a sulfate group to
galactocerebroside by the enzyme cerebroside sulfotransferase (CST). The
galactocerebroside is synthesized by the addition of a galactose group to ceramide by the
enzyme ceramide galactotransferase (CGT). (taken from Coetzee et al., 1998)
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Figure 4: (Upper left) A single PNS internodal segment is shown with the myelin sheath
unwrapped. The segment is flanked by paranodes and nodes of Ranvier. (Upper right) an
oligodendrocyte is shown with three processes terminating in three internodal segments,
again with the myelin sheath unwrapped. (Below) An axonal node of Ranvier is shown in
longitudinal-section. The three major regions are depicted: node, paranode, and internode.
The juxtaparanode is the internodal region immediately adjacent to the paranode on the
internodal side. As shown, sodium @a+) channels cluster in the node, CASPR 1 Paranodin
accumulates at the paranode, and rectifying potassium channels (Kvl.1 and Kv1.2) are
concentrated at the juxtaparanode. (Taken from Dupree, 1996)

Figure 4: Nodal / Paranodal Region Architecture
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expression is significantly upregulated, suggesting that Navl.2 may be used as a marker of
de- and or dysmyelination.

CST Null Mouse

Work in an animal model demonstrates the critical role of ST in the maintenance of
the paranodal region. Honke et al. (2002) engineered a CST null mouse in order to
determine whether a single gene and enzyme were responsible for the production of ST.
This mutant mouse displays minimal deficiencies through the early stages of development.
By 6 weeks of age these animals exhibit profound motor dysfunction in their hind limbs
accompanied by altered axo-glial interactions. These findings were confirmed by Marcus
et al. (2006), who showed that the absence of ST does not result in the gross disruption of
development, but that ST is essential for the maintenance of myelin and axon structure. In
the aged CST null mouse, nodal structure is compromised, axon diameter is decreased, and
neurons appear to be lost. Additionally, Ishibashi et al. (2002) reported that the initial
clustering of K+ and Na+ channels was only mildly altered in the young ST null mice;
however, with age and in the absence of demyelination, clusters of both the Na+ and K+
channels were lost, and K' channel clusters that remained were shifted to the paranodal
region. In addition, CASPR was dispersed throughout the internode rather than clustered
at the paranode. Taken together, these studies strongly suggest that ST is critical for the
maintenance of neuronal membrane organization, function and even survival.

Proper localization of sodium channels to the node of Ranvier and potassium
channels to the juxtaparanodal region are maintained by the integrity of the paranode. Is it
possible to use this organization of protein domains, which is maintained by rafts and
paranodal junctions, to measure changes in the interface between OLs and axons in AD. It
is feasible to observe such modifications by uitilizing irnrnunohistochemistry to visualize
+ K+channels in AD tissue.
any rearrangement of ~ a and

Rationale and Hypothesis

The cause of NFTs and AP plaques, the hallmark AD pathologies, is not clear.
Tangles and plaques are formed by enzymes that are preferentially sequestered to
membrane domains called lipid rafts. Sulfatide is essential for the proper structure and
function of lipid rafts. Our laboratory has demonstrated that reduced ST results in altered
membrane domains that are normally maintained by adhesive contacts and functional lipid
rafts. Sodium channel clusters at the nodes of Ranvier are lost as a result. This change in
sodium channel localization provides a useful measure for assessing overall alterations in
paranodal junctions and rafts. In this study, normal and age-matched AD brains will be
immunolabeled in order to evaluate the amount of clusters present. I hypothesize that
reduced ST in the AD brain disrupts lipid raft membrane domains as evidenced by loss of
sodium channel clusters at the node of Ranvier.

Materials and Methods

Tissue Acquisition and Storage

Human brain tissue was acquired fiom the University of California at Los Angeles
(UCLA) brain bank (Table 1). UCLA provided samples of occipital lobe. Tissue from
severe AD, mild AD and non-AD patients (based on Braak and Braak staging) was
requested, and 3 samples fi-om each category were received.
The brain bank ranked each patient according to the Braak and Braak criteria and as
cognitively normal or having dementia prior to death. The Braak and Braak stage refers to
the presence and location NFTs in the post-mortem pathological analysis. Lower Braak
and Braak scores (Table 1) correlated with 'no dementia' diagnosis, and higher scores with
diagnosis of 'dementia.'
The brain bank provided information on the duration between death and collection
of the tissue (ranging fiom 7 - 28 hours) although information for five of these samples
was lacking. All samples were fiesh frozen and shipped on dry ice. Upon receipt, the

Table 1: Information regarding the diagnosis of the patients and the post-mortem
pathologic state of the tissue obtained. Time post-mortem refers to period between death
and tissue collection. Braak and Braak stage was determined post-mortem primarily by the
extent of NFTs.

Table 1: TISSUE INFORMATION (1 sample each: occipital lobe)

20030027

AD-SEVERE Not provided

VI

20030030

AD-SEVERE

V

7:OO

Reagents Used

Tissue sections were stained with Quickstain (American Master*tech Scientific,
Inc.) in order to study the integrity of the tissue. The l x phosphate buffered saline (PBS)
used for IHC was composed of 160.lg NaCL, 28.8 g Na2HP04,4.8 g K&P04, 4.0 g KC1
dissolved in 20L of filtered water and made at pH 7.4. In order to localize sodi~miand
potassium channels, commercially available antibodies were used as previously described:
pan Na channel antibody (Sigma S8809) (Dupree et al.., 1999; Marcus et al., 2001), Na
channel Nav 1.2 (Upstate Biotechnology) (Dupree et al., 2005), and Kvl .1 potassium
channel antibody (Upstate Biotechnology) (Dupree et al., 1999). To assure that the density
of myelinated axons was comparable among samples, tissue sections were immunolabeled
with antibodies directed against neurofilaments (SMI33, Covance Research Products) and
the MT associated protein known as MAPlb (AA6, Sigma). An antibody against 2',3'Cyclic nucleotide 3'-phosphodiesterase (CNPase, SMI91, Covance Research Products) was
used to label myelin in order to distinguish between gray matter and white matter.
The standards for ST and cerebrosides were obtained from Avanti Polar Lipids
(cat# 131305 [ST] and 131303 [Cerebrosides]). A protease inhibitor cocktail (Sigma cat#
P8849) was used in the tissue homogenization process. Protein assay was performed using
a BSA kit obtained from Pierce Biotechnology, Inc.

Tissue Handling
The fresh frozen tissue was immediately stored at -80° C upon receipt. The tissue
was then slightly thawed in order to harvest small samples of WM enriched tissue that
were embedded in OCT compound (Tissue-Tek, Optimum Cutting Temperature, Sakura
Finetech). The OCT embedded tissue blocks were placed immediately on dry ice and
again stored at -80" C. Each tissue block was then sectioned at a thickness of 1Opm using
a cryostat at -20° C. Twenty-five consecutive sections were placed on slides (ProbeOn
Plus, Fisher), appropriately labeled (specimen#, brain region, section thickness, and slide
order), and stored at -80" C.

Immunostaining protocol
Imrnunohistochemical staining was performed according to the method of (Dupree
et al., 1999) Slides were removed from the freezer and allowed to air dry for 30 minutes.
Excess OCT was cut away from the perimeter of the tissue. A hydrophobic barrier was
applied around the section using a PAP pen (Super PAP Pen, Electron Microscopy
Sciences) to assist in maintaining incubation solutions on the section. Dried slides were
labeled to indicate antibody and incubated in -20" C acetone to permeabilize for 10 min.
The slides were then rinsed three times in phosphate buffered saline (PBS) for five minutes
each followed by a 30 minute incubation in a blocking solution. The blocking solution
contained -5% cold water fish skin gelatin (approximate since it was added dropwise and
is extremely viscous, 10% fetal calf serum, and 0.1% Triton-X 100 in PBS. Following the
block, sections were incubated in the appropriate primary antibody at the concentration

shown in Table 2. All antibodies used in this study have been well characterized in
previously published studies from laboratory (Dupree et al., 1999; 2005; Marcus et al.,
2002). The tissue remained in primary antibody overnight at 4" C in a humidified chamber
to prevent drying. The following day, three PBS rinses and 30 min blocking steps were
repeated, followed by a 90 min secondary antibody (Table 2) incubation in the dark at
room temperature. The secondary antibodies, which were fluorescently conjugated, were
also diluted in the blocking solution to a concentration of 1:200. The slides were then
rinsed three times in PBS for 5 minutes and mounted with Vectashield (Vector
Laboratories) medium and a cover slip was applied.

Controls, negative andpositive
Mouse tissue was analyzed along with human tissue under the same conditions in
order to confirm the specific binding of the antibodies. Since the specificity of the
antibodies used have been established in mouse tissue, and labeling patterns were
consistent between the two animals it was concluded that binding in the human occurred
and was specific. Labeling with different primary antibodies and the same secondary
revealed unique patterns of labeling and therefore assured the specificity of each. This
provided both positive and negative controls for the primary antibody. Tissue was also
stained with primary antibody and no secondary to ensure that the primary antibody did
not fluoresce. In order to confirm that the secondary antibodies only bound to the primary
antibodies used, IHC was performed in the absence of any primary antibody under
identical conditions.

Table 2: Primary and Secondary Antibodies Used

Table 2: Primary Antibody Concentrations and Corresponding Secondary
Antibodies with Conjugated Fluorochromes

Primary
Antibody
Dilution
Secondary
Antibody
(1:200)

Pan NaCh

Kvl .1

MAP 1b NaCh 1.2 Neurofilament CNPase

1:100
Alexa
594
AntiMouse

1:lOO
Alexa
594
AntiMouse

1:lOO
Alexa
594
AntiMouse

1:lOO
Alexa
594
AntiRabbit

1:lOOO
Alexa
594
AntiMouse

1:lOOO
Alexa 594
AntiMouse

Analysis of Sodium Channel Clusters

Quickstain
Each sample was stained with Quickstain in order to confirm the integrity of the tissue.
Tissue was analyzed for presence or lack of artifactual spaces. White matter without
significant space was deemed appropriate for IHC. One drop of dye was placed on a tissue
section for ten seconds and then rinsed in phosphate buffered solution (PBS) for 10
seconds. Slides were dried and cover slipped with immersion oil. Slides were visualized
under a Nikon Eclipse 800M bright field microscope and images were recorded at the GM
I WM interface at 40x and at 200x in each of the two regions (GM and WM).
Representative fields for each tissue section were chosen and recorded. Consecutive
sections were analyzed by Quickstain and by IHC for NaCh clusters.
The first step in analyzing each slide was to distinguish between WM and GM.
Prior to nodallparanodal protein data collection, myelin markers were used for this purpose
(as previously discussed). In addition to the myelin antibody markers, distinct patterns of
lipofuscin (LF), corresponding to the WM and GM region, was observed. Subsequently,

LF patterning was used to make the distinction.

Confocal Microscopy
After confiiing areas, of white matter, all sections were imaged using the Leica
TCS SP2 AOBS or Zeiss LSM510 NLO META confocal microscopes housed in the VCU
Microscopy Facility. A minimum of six fields were collected, depending on the size of the
WM region in each sample. In all cases, except for Kvl .l data collection, a single optical
plane was scanned. In the case of the Kvl .1,a maximum projection of a z-stack of 10
optical planes at a step size of 0.4 pm was collected in order to capture pairs of potassium
channel clusters in different planes. Gain and offset settings were held as consistent as
possible from fiame to frame. Following is a list of settings used for image collection
(Table 3).

Digital Removal of Autoflourescence
One of the difficulties of fluorescent labeling of human tissue is the presence of the autofluorescing substance known as lipofuscin (LF). LF accumulates in cell bodies and is
composed of lipids, metals, organic molecules, and biomolecules (as reviewed by Brunk
and Terrnan, 2002). LF emits fluorescence in the red spectrum when excited with 488 and
594 nm light. The majority of the experiments were performed with a secondary antibody
that was optimally excited at 594 nm and which also emitted light in the red spectrum.
Since both the fluorescent label and LF emitted in the same region of the spectnun, it was
not possible to discern specific labeling from LF autoflourescence. Two techniques were
employed to resolve this issue. On the Leica confocal microscope, a subtraction technique
was used.

Table 3: These settings were determined to be optimal for the information desired.

Table 3: Confocal microscope settings
Gain

Offset

Leica

700 +I- 71

0 +I- 0.05

Zeiss

700 +I- 63

0 +I- 0.05

Pinhole
Diam.
115-pm = 1
Airy Unit

Zoo
m
2

Objective

Format

63x

1024x
1024

112 pm = 1
Airy Unit

2

63x

1352x
1352

Line
Av
4
4

Voxel
Size
116.14 x
116.14
nm
98.82 x
98.82

nm

Briefly, when excited by the 488 nm laser, ordy LF fluorescence was present, and thus all
pixels visible in this image corresponded to LF. Another image was taken under 594 nm
light that contained specific labeling for the antibody used as well as LF autoflouresence.
All pixels from the 488 image were subtracted from the 594 image leaving only pixels
corresponding to the protein of interest. The subtraction method was not ideal, however,
since in the instance of pixels that overlapped between the two channels, the signal of the
desired channel was diminished or eliminated.
In addition to the subtraction method, autoflourescence and antibody labeling were
also distinguished by the Zeiss spectral unmixing capabilities of the META system of the
Zeiss confocal microscope. With the exception of the neuronal markers to neurofilaments
and MAP 1b, used to determine axon density, all of the IHC experiments were completed
on the Zeiss confocal microscope in order to use its META capabilities. Since only ratio
between the clusters (measured on the Zeiss) and axon density (measured on the Leica)
was needed, data from one microscope could be used to analyze data from the other. The
META detector was a polychromatic 32-channel detector for fast acquisition of lambda
stacks and allowed simultaneous acquisition of up to 8 channels. Multiple images of the
same field were gathered - each scanned using incremental emitted wavelengths from 447704 nm. These data were compiled in order to create profiles of the fluorescing intensity
for each emitted wavelength at each pixel. The profiles were curves plotted with
fluorescent intensity on the y-axis and the spectrum of emission wavelengths on the xaxis.

Profiles of specific pixels were then chosen as representative of each fluorescent
species (i.e. 594, lipofuscin, background). All signals that identified with profiles for LF
and background were digitally removed from the image. Thus, only pixels corresponding
to the 594 fluorochrome (which was conjugated to the secondary antibody and
corresponded to the immunolabeled protein of interest) remained in the recorded image.
This procedure, called linear untnixing, was a more precise method of identifying which
pixels correspond to specific secondary antibodies since it was able to distinguish even
between overlapping pixels based their the spectral fingerprints (Figure 7).

Quantitation of sodium channel clustering
Following spectral unrnixing, the clusters of sodium and potassium channels were
counted with IPLAB (Scanalalytics, Inc) software using segmentation analysis. The
threshold was set such that the number of clusters counted for several fields corresponded
approximately to the numbers generated by counting manually. In the cluster counts
IPLAB's segment quantification feature was used with settings including pixels with
intensities between 50 and 255 and clusters having areas of between 9 and 1000 pixels
(9,800 nm21pixel). The threshold (intensity) and cluster size settings were optimized in an
attempt to reproduce the choices made by eye as to what constituted a cluster and to
reproduce manual counts. These setting were chosen by first counting several different
frames manually. The same frames were then subjected to quantification analyses with
various combinations of intensity threshold and number of pixels per cluster settings. The
optimal settings were chosen when the clusters outlined by the software resembled the

shape and size of those seen in the raw images and the numbers of clusters counted by

IMAGEJ (httv://rsb.info.nih.gov/ii/) were similar to those that were manually obtained.
To assure comparisons of structurally similar brain regions, axon fiber densities
were calculated using axonal markers based on percent labeled pixels per field. As
previously indicated, an antibody to MT associated protein 1b (MAP 1b), which is a good
indicator of axonal MTs, was used as well as an antibody directed against neurofilaments.
For this quantification, Image J software was utilized to count all pixels in a field that had
intensities between 70 and 255 on the thresholding feature of the software. This range was
chosen by simultaneously viewing thresholded and original images to create and image
which only revealed pixels pertaining to axons. Sodium channel clusters were counted and
then standardized based on the obtained axon densities. Cluster counts were divided by
axon densities generating numbers in clusters 1 Clm2of axon / field.

Statistics

One section of each sample was analyzed. Every ninth field was recorded such that
a nzinimum of six fields analyzed depending on the amount of WM per sample All values
are presented as mean +/- standard deviation (SD). All data were statistically analyzed by
t-test or analysis of variance (ANOVA) where appropriate, using Sigmastat software
package (Systat Software Inc.) with the assistance of Dr. David Sirnpson, Associate
Professor of Anatomy and Neurobiology at VCU. Significance was set at p < 0.05.

Thin layer analysis of sulfatide content

Lipid Extraction
Lipids were extracted as previously published by Sato and Yu (1990). Dr. Carmen SatoBigbee, Associate Professor of Biochemistry and Emilse Sanchez guided this portion of
the study and all TLC procedures were conducted in Dr. Sato-Bigbee's laboratory.
Briefly, for the extraction, 11Omg of WM enriched samples were harvested (confimed
by visual inspection). For each specimen, the tissue sample was homogenized in 500uL
of PBS that contained a protease inhibitor cocktail (Sigma cat# P8849) on wet ice. An
aliquot of homogenate was set aside at 4' C for protein analysis. A 200uL aliquot of the
homogenate was added to 40 volumes of choloroform:methanol2:1. All of the steps after
homogenization were performed at room temperature. Each sample was then centrifuged
at 2000 rpm for 10 min. The supernatant was transferred to a fiesh 15rnl plastic
graduated tube (Falcon, Fisher Scientific). Distilled water in the amount of 20% of the
original solvent volume was then added. The sample was shaken, allowed to settle, and
centrifuged at 1000 rprn for 5 min. The top of the upper layer (the aqueous phase) was
marked on the tube and the upper layer was removed. The tube was filled to the mark
with Ch1oroform:Methanol:Water (4:48:47). The sample was shaken, settled, and

centrifuged at 1000 rpm for 5 rnin. The upper 2 layers, the aqueous and interphase, were
removed and the sample was dried under nitrogen in order to prevent oxidative
degradation. The sample was then resuspended in chloroform:methanol2: 1 in 20% of
initial solvent volume. After the extraction, volumes of the organic layer, which

38
contained the lipids, varied, suggesting that water content varied among the samples.
These volume values were used later to standardize the TLC results.
To determine which bands correlated with ST, cerebroside and ST standards were
run next to samples on the TLC plate. The standards for ST and cerebrosides were
obtained from Avanti Polar Lipids (cat# 131305 [ST] and 131303 [Cerebrosides]). Stock
solutions of standards were at 1.7 pg/pL in 2: 1 chloroform:methanol.

Preparation of tissue
Optimal loading amount of the sample was predetermined for GM and WM based
on a TLC of a series of increasing amounts of lipids. Loading volumes were made by
pipetting various masses of total lipids into disposable glass culture tubes (Baxter
12x75mm) and drying under nitrogen. Samples were then redissolved in 10 pL of 2:l
Chloroform:Methanol, the optimal TLC loading volume as previously determined by
(Sato and Yu, 1990). The samples were cortical regions enriched in WM (11Omg). The
mass of the human samples was chosen based the amount of WM available. A TLC of a
series of amounts of lipids (Figure 12) was performed on non-diseased WM and GM
samples at concentrations: 5, 10, and 20 pL (dried under nitrogen and redissolved in 10
pL of choroform:methanol). The 5uL band was too faint and the 10 pL band too large
(Figure 13). Therefore, 7.5 pL was determined to be the optimal load for WM. One and
three pL volumes of standards (1.7 ug / pL) were diluted to 10uL and loaded.

TLC Plate loading and developing
The TLC protocol was as follows: The silica gel plate (obtained fiom EMD
Chemicals cat# 1176416) was activated by heating at 130' C for two hours. The samples
were immediately loaded on the plate on 1.0 cm lines spaced 0.5 cm apart. The material
was loaded 1.5 cm fiom the bottom of the plate to ensure that the solvent in the TLC well
did not contact the sample. A 25mL Hamilton glass syringe with a blunt tip was used for
loading. Samples were added dropwise. The plate was placed vertically in the well such
that less than 1.5 cm of the plate was immersed in the solvent solution of methyl

acetate:chloroform:methanol:l-propano1:water (2528: 10:25:7) and the well was sealed.
The samples were allowed to run until the progress of the mobile phase had visibly
ceased to progress. The plate was stained with orcinol which has been shown by Zoller et
al. (2005), to be especially effective in staining ST and the images were recorded with a
Fluorochem Imaging system (Alpha Innotech)

Protein Assay
In order to further standardize our TLC data, a protein assay was performed.
Aliquots of the tissue homogenate were used to determine the total concentration of
protein in the sample. 300uL of the initial 500uL homogenate of the tissue samples was
used for the assay. This volume was diluted with 1mL of radioimmunoprecipitation

(FUPA) buffer solution and further homogenized in a 15rnL disposable tissue grinder
(VWR International, 47732-446). RIPA buffer was added to reach a dilution of 1:20 of
the original 300pL aliquot. The tissue was further homogenized in a glass tissue grinding
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tube with a ceramic pestle bit in a ring-stand mounted drill. The sample was then assayed

for total protein content at several dilutions. The assay used was a Pierce BSA kit that
measures total tryptophan residues. The assay was performed on each sample in
triplicate along with a standard curve using bovine albumin. Protein concentrations were
measured using an ELISA plate reader at 570 nrn.

Quantification of TLC's
The densities of bands were measured with ImageJ image analysis software.
Densities were calculated by selecting the combined hydroxylated and non-hydroxylated
ST bands and calculating the area under the peaks in curves corresponding to the bands.
From the densitometry data, a total number of optical density units for the entire 1lOmg
tissue sample was extrapolated. Considering that the number of OD units for the ST
bands for a given lane correspond to the amount of ST in volume of lipids loaded, a
concentration in the form of OD units per mL of lipid extract can be calculated. Using
the fiaction of the homogenate which the lipid extract constitutes, OD units per mL of
homogenate can be calculated. Since the tissue was homogenized in 500mL of PBS,
multiplying the OD units of ST / mL homogenate by 500 will give total OD units of ST
for the tissue sample. A total amount of protein (in mg) for the harvested sample was
calculated. A standard curve was generated from the ST standards of known
concentration versus optical density enabling the conversion of the density of ST in the
samples to be converted to mass. The densities of the ST bands were standardized
relative to the cerebroside and cholesterol lipid bands as well as to total protein content.
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Results were reported as pg ST / pg protein and pg ST / pg cerebroside. A one-way
ANOVA among the sample groups was performed on the standardized values for ST
content.

Results

Immunohistochemistry
Immunohistochemistry (IHC) techniques were employed to evaluate the
competency of the axo-glial interactions in the AD tissue based on the clustering of
sodium channels. For these studies, fiesh frozen tissue saniples were immunolabeled for
several paranodal and nodal proteins known either to mediate axo-glial interactions or
whose distribution is directly altered when these mediations are compromised (Menegoz
et al., 1997; Dupree et al., 1999; Rios et al., 2000; Ishibashi et al., 2002).

Tissue samples
Quickstain analysis revealed that the WM of the most samples was in tact (Figure

5). Some holes were present in GM, though minimal. Only those tissues which were
judged to be in good condition were used.

Gray and white matter regions determined by myelin markers and lipofuscin patterns
As shown in Figure 6, distinct patterns of lipofuscin exist for gray matter and
white matter. These regions were initially determined by myelin markers. CNP was used
as a myelin marker and provided very clear visualization of distinct GM and WM
regions. CNP labeling confirmed that the distinct patterns of a~ltofluorescencewas a
reliable method of differentiating GM and WM regions.

Axonal orientation and girth consistent among samples
First, to assure that .the density of myelinated axons was comparable among
samples, tissue sections were immunolabeled with antibodies directed against
neurofilaments (SMI33, Covance Research Products) and the MT
associated protein known as MAPlb (AA6, Sigma). An antibody against 2',3'-Cyclic
nucleotide 3'-phosphodiesterase (CNP) was used to label myelin in order to distinguish
between GM and WM.
Using qualitative assessment, it was determined that the regions analyzed
contained homogenous populations of axonal processes with respect to caliber and
density. Due to the fact that the qualitative analysis showed uniformity among samples
and that most of the axons in all samples were in oblique section, density was determined
to be a reliable correlate to axon length. Since the number of clusters is dependant on
axon length, the cluster counts were standardized based on axon density. In other words,
the number of ion channel clusters per field was divided by the density of axonal staining
per field.

Figure 5: Samples were stained with Quickstain to assess degree of artifact. Images
shown are representative of condition of the typical sample. What little artifact is present
is in the form of spaces within the tissue as shown by the arrows, which is probably due
to freezing. Typical fields of A) GM, B) WM. The GM regions consistently show greater
artifact than WM.

Figure 5: Typical Tbne Samples Show Only Minor Artifact
A) Gray hiatter

B) White Matter

Figure 6 a, b: a) GM exhibits larger clusters of lipofuscin autoflouresence yet the clusters
are less uniform in distribution, shapes and sizes compared to b) WM which lacks neuronal
cell bodies and thus smaller clusters of LF are observed in a more regular pattern. Neither
(a) nor (b) were treated with primary antibody, but were otherwise subjected to the
identical protocol as the other IHC experiments, and thus no specific immunolabeling is
present in these images.
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Fire 6 a, b: Lipofnscin patterns used to differentiate gray and white matter
a) Gray Matter

b) White Matter

Figure 7 a, b: a) Lipofuscin (yellow) makes sodium channel clusters (white) difficult to
identify. b) Lipofuscin signal has been removed via lambda scanning and linear
unrnixing .

Figure 7: Lipofuscin removal made sodium channel cluster identiileation passible
a) Pan NaCh labeling with lipofuscin
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Axonal markers revealed slight variations in axon densities
Axonal markers to MAPl b and neurofilaments were used to compare relative axon
densities between brain regions. Both qualitative and quantitative assessments were used
to compare tissue samples. Among the samples, axon girth appeared constant; few axons
were longitudinally oriented; most axons were transversely or obliquely oriented. The
results from this analysis are shown below in Table 4 and Figure 8. These densities were
used to standardize the protein clustering values. MAPl b yielded a mean axon density of
2 17 +I- 105 pixelslfield for severe AD, 200 +I- 105 for mild, and 173 +I- 19 for non-AD
with a p value of 0.9. Neurofilament densities were 186 +I- 75 for severe, 143 +I- 23 for
mild, and 174 +/- 36 for the controi and a p value of 0.6.
Nodal architecture was intact
IHC studies on the ST null mouse revealed dramatic alteration in protein clusters
(Ishibashi et al., 2002). To test whether the nodal changes seen in the ST null mouse were
also present in AD, the distribution of several CNS nodal and paranodal proteins was
determined. Negative control labeling with secondary antibodies in the absence of
primary antibodies revealed no specific labeling.

Sodium channels were unchanged between sample groups
In the non-standardized cluster counts from the pan NaCh there was no significant
difference between AD and non-AD as seen in Table 5 and Figures 9, 10, and 11. Age-

Figure 8: Variability in axonal labeling among samples: Samples were labeled
with antibodies directed against axonal cytoskeleton in order to calculate axon
density

Figure 8 a, b, c, Bi d: Variability in axoml labeliag seen among samples

Table 4: Axon densities were measured in number of pixels per fiame of labeling for
Maplb and neurofilaments above an intensity of 50 (on a scale of 0-255). Means and
standard deviations are given for each disease or non-disease group.

Table 4: Axon densities varied among samples

Figure 9 a, b: Pan NaCh Labeling Unchanged Between Non-Alzheimer's and
Alzheimer's Tissue These figures demonstrate the clustering seen in sodium
channels at the nodes of Ranvier. Mouse monoclonal pan NaCh primary antibody
was used at 1:100; Alexa 594 conjugated anti-mouse secondary antibody at 1:200.

Fire 9: Pan Sodium Channel Labeling Unchanged

b) Alzheimer's Pan NaCh Labeling
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matched, non-demented brains revealed the same cluster mean (329 +/- 68 clusters/field)
as the severe diseased (308 +/- 170 clusters/field) and the mild diseased (28 1 +/- 104)
brains. When standardized against axon density (Figure 1I), the pan NaCh antibody again
revealed no significant difference (P = 0.235) among the sample groups as determined by
aone-way ANOVA. Raw and standardized means among groups showed similar trends.

Navl. 2 sodium channels unchanged

Despite the fact that the pan NaCh antibody showed no difference between sample
groups, it remained to be determined whether clustering of specific Na channel isoforms
was altered. Quantification of the clustering of Nav 1.2 removed this ambiguity as well as
serving as a marker for demyelinating pathology. This antibody revealed no significant
difference (P = 0.142) between AD and non-AD groups for either clusters or total area
(Table 6). It was therefore concluded that there were no differences between these sample
groups for the Nav 1.6.

Thin Layer Chromatography
No Difference in ST Levels Among Samples

Considering the premise of the study was the previous findings of Gottfries,
Karlsson, and Svennerholni (1996), and more recent data from Han et al. (2002), who
reported a 60% decrease in WM ST, TLC was employed to c o n f i these results. Upon

Figure 10: Shown in purple are the average number of total pixels per field of MAPl b
labeling (representing axon density). In red are the average number of clusters of sodium
channels per field. The first three pairs represent severe AD, the second three, mild, and
the third, non-diseased. This figure demonstrates how the axonal marker MAPl b and
NaCh clustering varied in parallel with each another.

Figure 11: This figure shows the mean number of clusters per field divided by the mean
axonal density as determined by MAPlb immunolabeling. A slight trend can be detected
in this graph, though an analysis of variance revealed any differences to be insignificant.

Iq M

ce ii$t'SdhmC!hfm&l C b t m Standardized with MAPlb

Table 5: This table contains mean number of clusters per field for NaCh for the three
sample groups of the tissue in the 'NaCh' clusters columns. Columns headed 'NaCh' /
MAP1b' or SMI 33 show cluster counts standardized by dividing by axon density.

Table 5: Ne DHZhmee4n sodium dPotassixam Channel Cl'llsters
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initial inspection by eye, there appeared to be no difference among sample groups (Figure
13). Densitometry with ImageJ analysis software revealed that there was a trend towards a
decrease in ST in the AD groups although the differences were not significant. One TLC
was preformed and densitometry was performed on one band of each sample. In the
analysis ST levels were determined to be slightly higher in the control group than in the
mild and severe AD groups (Table 7, Figure 13). The control group revealed 0.48 +I- 0.05
pg ST / OD units of cholesterol compared to the mild group, which presented a ratio of

0.36 +I- 0.01. Similarly the severe group exhibited a ST to cholesterol ratio of 0.36 +/0.07. A one-way ANOVA gave a P-value for these three groups of 0.201.

Table 6: Shown are total segments/field and areaslfield of labeling of anti-Navl.2 primary
antibodies in the tissue

Figure 12: This figure shows from left to right - two lanes of cerebroside standards: 0.02
and 0.06 pg; two lanes of ST standards (2 bonds: non-hydroxylated above hydroxylated)
0.02 and 0.06 pg; three lanes of WM enriched non-diseased human brain extract: 5, 10,20
pL of extract; and three lanes of GM at 5,10 and 20uL of extract. Nothing was loaded on
the empty lane between the 5 pL and 10 pL GM.

Figure 12: 15pL Determined Optimal Loading Volume for White Matter

0.02p.gO.06pg 0.02pg 0.06p.g

Cerebrosides

Sulfatide

5p.L l0uL 20uL 5uL

White Matter

0

Gray Matter

lOuL 20uL

Figure 13: The TLC shows the various lipid bands found in the white matter enriched
human brain tissue samples. The top band is cholesterol (Ch), the next two bands are
cerebrosides (non-hydroxylated above hydroxylated) as can be seen by the cerebrosides
(C) standard bands seen on the left. The next two bands correspond to ST (nonhydroxylated above hydroxylated) as seen in the (ST) standards the left.

Figme 13: No Change in White Matter Subtide Levels Among Sample Groups
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17
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Mild AD

28

36

24
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Table 7: Shown are the standardized optical densities of the ST bands from TLC analysis
of the tissue. The ST was standardized by the cholesterol band as shown in the 'ST /
cholesterol' column. ST was also standardized by protein.

Table 7: No Difference in White Matter Sulfatide Levels

Severe

Mild

Control

Sample
27
30
17

W S T I P ~ PgST/Pg
Cholesterol
Protein
0.36
48
81
0.29
0.43
62

DISCUSSION

Alzheimer's disease is characterized by accumulation of AP plaques, NFTs and
neuronal death, though the cause of these hallmark pathologies remains unclear. Enzymes
that are involved in the formation of AP plaques and NFTs are associated with the
neuronal membrane (Kramer et al., 1999; Ehehalt et al., 2003), and proper partitioning in
the normal membrane prevents inappropriate interaction of axolemmal enzymes and
potential substrates (reviewed by Simons and Ikonen, 1997). Sulfatide is essential for the
proper structure and function of lipid rafts, and Han et al. (2002) recently reported that ST
is significantly reduced even in the earliest stages of AD. Thus, I hypothesized that
reduced ST in the AD brain would disrupt lipid raft membrane domains as evidenced by
loss of sodium channel clusters at the node of ranvier. In the present study, membrane
domain organization appeared to be in tact in AD tissue. Sulfatide levels also appeared to
be unchanged. I was therefore unable to support my hypothesis.

Protein Organization

Sodium channel clustering was used as a marker to determine membrane domain
organization since it is well characterized and easily labeled. Clusters were unchanged in

AD tissue at both early and late stages as compared to controls.

Simons and Ehehalt, 2002 and Ehehalt et al., 2003 suggested that rafts are involved Af3
formation. When cholesterol was depleted Af3generation increased and a-cleavage (nonamyloidegenic) increased. Cholesterol depletion would disrupt raft organization and
render more of the usually raft associated APP in non-raft membrane domains.
We decided therefore to analyze protein organization in the axolemma as a measure of raft
integrity. Imrnunohistochemical analysis, confocal microscopy, and digital quantification
were rigorously performed.
Our findings do not suggest a loss in neuronal membrane organization, suggesting
that the increased f3-amyloidogenicprocessing in AD is due to some mechanism other than
rafi disruption This supports the findings of Simons since raf3 disruption would be
expected to increase non-disease causing APP processing and decrease Af3production.
This opens the possibility that hyper aggregation of rafts is actually responsible for the
increased P-cleavage activity that ultimately leads to the formation of amyloid plaques.

Sulfatide in Alzheimer's Disease

In the thin layer chromatography analysis of the lipid content, ST was not
significantly different in the AD and non-AD brains. Our findings are in contrast to those
of both Han et al., 2002 and Gottfries et al., 1996. Both of these previous studies showed a
significant decrease in ST in AD.
Han and colleagues showed a 60% decrease in WM using electrospray ionization
mass spectrometry, which is a more sensitive method for quantitative analysis of Sulfatide
than TLC. Although TLC is a less sensitive it is unlikely that the 60% decrease observed

in the Han study would not have been detected. Gottfries et al., 1996, differentiated
between early and late AD and compared them both to non-AD tissue in their study of
brain lipids. They used TLC to analyze ST content in the late onset tissue and compared
-thisto the control, revealing nearly a 40% decrease. In the present study we did not
differentiate between early and late onset AD, and herein may lay the reason for the
conflicting data.
Considering that we only studied white matter and Gottfries did as well, yet Han
also saw a decrease in ST in GM, it is possible that the ST level decrease that is truly
important in AD pathogenesis is that in GM. Since the hallmark pathologies of AD are
associated with the neuron, it would very possible that a decrease in GM ST would have a
direct role in AD.

Caveats

Differences in axon density, caliber, and orientation among samples were a concern
due to lack of specific information on the location of harvest. This concern was essentially
eliminated by standardization with axon density and qualitative analysis of axon girth.
Variation in duration between time of death and time of harvesting was initially a concern
since it might possibly be cause for tissue degradation due to lipidases. The white matter
was largely in excellent condition suggesting that state of membrane organization revealed
by the sodium channel data could be trusted. Due to the high water content in WM of live
tissue and the inconsistency in post-mortem treatment of our tissue, there was a possibility
that the dry weight of the tissue, and therefore total lipids, harvested varied among

samples. In order to control for this a protein assay was performed. Standardization by
protein mass did not significantly change the relative ST concentrations among sample
groups suggesting that variations in water content was not a significant source of error.
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